Answers are grounded in this paper and cite their sources.
Synucleinopathies, including Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy, are characterized by convergent α-synuclein misfolding, impaired proteostasis, and chronic neuroinflammation. Despite these shared pathological features, these disorders exhibit distinct inclusion-bearing cell profiles, vulnerable neural circuits, immune phenotypes, and clinical progression rates, with neuronal inclusions dominating in Parkinson's disease/dementia with Lewy bodies and oligodendrocyte pathology predominating in multiple system atrophy. Extracellular vesicles have emerged as critical modulators integrating these multifaceted pathogenic processes. Secreted by neurons, astrocytes, microglia, oligodendrocytes, endothelial cells, and peripheral immune cells, extracellular vesicles cross biological boundaries to deliver diverse bioactive molecules and mediate intercellular communication. This review synthesizes current evidence to propose that extracellular vesicles serve as context-dependent mediators connecting intracellular proteostatic stress to local glial reactivity and systemic immune regulation. Extracellular vesicle-associated α-synuclein maintains a seeding-competent conformation, enters recipient cells, and triggers templated aggregation and inflammatory signaling, although its exact pathogenic contribution relative to free α-synuclein and non-vesicular transmission routes remains undefined. Extracellular vesicle cargo dynamically reshapes microglial and astrocytic activation, oligodendroglial homeostasis, neuronal survival, blood-brain barrier integrity, and peripheral immune recruitment. Extracellular vesicles exert bidirectional effects: pathological extracellular vesicles amplify neurotoxicity, while homeostatic or engineered extracellular vesicles restore proteostasis, optimize immune homeostasis, and facilitate neural tissue repair. Advanced techniques including immunocapture, real-time quaking-induced conversion, and single-vesicle profiling enhance the sensitivity and resolution of extracellular vesicle-based biomarkers, enabling improved discrimination among synucleinopathy subtypes. However, clinical translation is hampered by extracellular vesicle heterogeneity, inaccurate cell-origin tracing, pre-analytical variability, insufficient standardization, and limited causal in vivo and longitudinal evidence. It is concluded that extracellular vesicles function as integral components of a dynamic, multilayered communication network, with their outcomes determined by cellular origin, cargo, recipient type, disease stage, and anatomical context. Standardized protocols, longitudinal cohorts, and mechanistic models are indispensable for developing reliable extracellular vesicle biomarkers and safe extracellular vesicle-targeted therapies for synucleinopathies.
No takes yet. Share an insight, caveat, or question.
Cui et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: